Department of Clinical Neurosciences, Western General Hospital, Edinburgh.
Division of Neurosurgery, Addenbrooke's Hospital and University of Cambridge, Cambridge.
J Neurosurg. 2017 Oct;127(4):732-739. doi: 10.3171/2016.8.JNS16134. Epub 2016 Nov 11.
Symptomatic chronic subdural hematoma (CSDH) will become an increasingly common presentation in neurosurgical practice as the population ages, but quality evidence is still lacking to guide the optimal management for these patients. The British Neurosurgical Trainee Research Collaborative (BNTRC) was established by neurosurgical trainees in 2012 to improve research by combining the efforts of trainees in each of the United Kingdom (UK) and Ireland's neurosurgical units (NSUs). The authors present the first study by the BNTRC that describes current management and outcomes for patients with CSDH throughout the UK and Ireland. This provides a resource both for current clinical practice and future clinical research on CSDH.
Data on management and outcomes for patients with CSDH referred to UK and Ireland NSUs were collected prospectively over an 8-month period and audited against criteria predefined from the literature: NSU mortality < 5%, NSU morbidity < 10%, symptomatic recurrence within 60 days requiring repeat surgery < 20%, and unfavorable functional status (modified Rankin Scale score of 4-6) at NSU discharge < 30%.
Data from 1205 patients in 26 NSUs were collected. Bur-hole craniostomy was the most common procedure (89%), and symptomatic recurrence requiring repeat surgery within 60 days was observed in 9% of patients. Criteria on mortality (2%), rate of recurrence (9%), and unfavorable functional outcome (22%) were met, but morbidity was greater than expected (14%). Multivariate analysis demonstrated that failure to insert a drain intraoperatively independently predicted recurrence and unfavorable functional outcome (p = 0.011 and p = 0.048, respectively). Increasing patient age (p < 0.00001), postoperative bed rest (p = 0.019), and use of a single bur hole (p = 0.020) independently predicted unfavorable functional outcomes, but prescription of high-flow oxygen or preoperative use of antiplatelet medications did not.
This is the largest prospective CSDH study and helps establish national standards. It has confirmed in a real-world setting the effectiveness of placing a subdural drain. This study identified a number of modifiable prognostic factors but questions the necessity of some common aspects of CSDH management, such as enforced postoperative bed rest. Future studies should seek to establish how practitioners can optimize perioperative care of patients with CSDH to reduce morbidity as well as minimize CSDH recurrence. The BNTRC is unique worldwide, conducting multicenter trainee-led research and audits. This study demonstrates that collaborative research networks are powerful tools to interrogate clinical research questions.
随着人口老龄化,症状性慢性硬脑膜下血肿(CSDH)在神经外科实践中将会越来越常见,但仍缺乏高质量证据来指导这些患者的最佳治疗方法。英国神经外科住院医师研究协作组(BNTRC)由神经外科住院医师于 2012 年成立,旨在通过联合英国和爱尔兰神经外科单位(NSU)的住院医师的努力来改善研究。作者首次展示了 BNTRC 的一项研究,该研究描述了英国和爱尔兰 NSU 收治的 CSDH 患者的当前治疗方法和结局。这为 CSDH 的当前临床实践和未来临床研究提供了资源。
在 8 个月的时间内,前瞻性收集了转诊至英国和爱尔兰 NSU 的 CSDH 患者的管理和结局数据,并根据文献中预先定义的标准进行了审核:NSU 死亡率<5%,NSU 发病率<10%,60 天内需要再次手术的症状性复发<20%,NSU 出院时功能状态不良(改良 Rankin 量表评分 4-6)<30%。
共收集了 26 个 NSU 中 1205 例患者的数据。颅骨钻孔术是最常见的手术(89%),9%的患者在 60 天内出现需要再次手术的症状性复发。死亡率(2%)、复发率(9%)和功能结局不良(22%)的标准得到满足,但发病率高于预期(14%)。多变量分析表明,术中未插入引流管独立预测复发和功能结局不良(p=0.011 和 p=0.048)。患者年龄增加(p<0.00001)、术后卧床休息(p=0.019)和使用单个颅骨钻孔(p=0.020)独立预测功能结局不良,但使用高流量氧气或术前使用抗血小板药物并未预测功能结局不良。
这是最大的前瞻性 CSDH 研究,有助于建立国家标准。它在真实环境中证实了放置硬脑膜下引流管的有效性。本研究确定了一些可改变的预后因素,但对 CSDH 管理的某些常见方面提出了质疑,例如术后强制卧床休息。未来的研究应探讨如何优化 CSDH 患者的围手术期护理,以降低发病率并最大限度地减少 CSDH 复发。BNTRC 在全球范围内是独一无二的,它开展了多中心住院医师主导的研究和审计。本研究表明,协作研究网络是研究临床研究问题的有力工具。